XML 17 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders’ Equity (deficit) - USD ($)
$ in Thousands
Total
At-the-Market Offering
Common stock
Common stock
At-the-Market Offering
Additional paid-in capital
Additional paid-in capital
At-the-Market Offering
Accumulated deficit
Accumulated other comprehensive loss
Beginning balance (in shares) at Dec. 31, 2023     161,113,744          
Beginning balance at Dec. 31, 2023 $ (24,481)   $ 16   $ 469,081   $ (483,061) $ (10,517)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock under stock-based compensation plans (in shares)     561,266          
Issuance of common stock under stock-based compensation plans 8       8      
Stock-based compensation 5,515       5,515      
Tax withholding related to vesting of restricted stock units (734)       (734)      
Foreign currency translation adjustment, net of tax 47             47
Net loss (17,312)           (17,312)  
Ending balance (in shares) at Mar. 31, 2024     161,675,010          
Ending balance at Mar. 31, 2024 $ (36,957)   $ 16   473,870   (500,373) (10,470)
Beginning balance (in shares) at Dec. 31, 2024 266,595,867   266,595,867          
Beginning balance at Dec. 31, 2024 $ 62,646   $ 27   700,069   (626,940) (10,510)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Issuance of common stock in connection with the ATM agreement, net of issuance costs (in shares)       24,604,021        
Issuance of common stock in connection with the ATM agreement, net of issuance costs   $ 146,108   $ 2   $ 146,106    
Issuance of common stock in connection with exercise of stock options and vesting of RSUs (in shares)     151,121          
Issuance of common stock in connection with exercise of stock options and vesting of RSUs 23       23      
Issuance of common stock in connection with exercise of warrants (in shares)     394          
Issuance of common stock in connection with exercise of warrants 6       6      
Stock-based compensation 4,046       4,046      
Tax withholding related to vesting of restricted stock units (517)       (517)      
Foreign currency translation adjustment, net of tax 498             498
Net loss $ (5,421)           (5,421)  
Ending balance (in shares) at Mar. 31, 2025 291,351,403   291,351,403          
Ending balance at Mar. 31, 2025 $ 207,389   $ 29   $ 849,733   $ (632,361) $ (10,012)